Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19

Detalles Bibliográficos
Autores principales: Marchetti, Giulia, Rovito, Roberta, Bono, Valeria, Bonara, Paola, Bai, Francesca, Monforte, Antonella d’Arminio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868007/
https://www.ncbi.nlm.nih.gov/pubmed/36702398
http://dx.doi.org/10.1016/j.cmi.2023.01.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868007/
https://www.ncbi.nlm.nih.gov/pubmed/36702398
http://dx.doi.org/10.1016/j.cmi.2023.01.016

Ejemplares similares